| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: what is presented is a group of inventions involving a pharmaceutical composition for preventing or treating diabetes mellitus, diseases related to diabetes mellitus, or complications of diabetes mellitus containing a combination of (A) (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol, or its salt, hydrate or hydrate salt, and (B) metformine or an agent intensifying insulin secretion, and a combination of the same formulation and for the same application.EFFECT: in addition to the pronounced blood plasma glucose reduction, the synergetic effect is ensured in inhibiting the plasma insulin level; what is also shown is inhibiting the side effect of glimepiride that is a body weight increase.16 cl, 20 tbl |
